Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related antibody Quavonlimab (Anti-CTLA-4 / CD152) For research use only.
Not for use in humans.

Quavonlimab (Anti-CTLA-4 / CD152)

Synonyms: MK-1308

Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

Quavonlimab (Anti-CTLA-4 / CD152)

Purity & Quality Control

≥99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

Product Details

CAS No. 2254059-25-9
Isotype Human IgG1
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) supplier | purchase Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) cost | Quavonlimab (Anti-CTLA-4 / CD152) manufacturer | order Quavonlimab (Anti-CTLA-4 / CD152) | Quavonlimab (Anti-CTLA-4 / CD152) distributor